Literature DB >> 9357420

Hepatic encephalopathy and ascites.

R Jalan1, P C Hayes.   

Abstract

The first abnormality leading to sodium and water retention in cirrhosis is the renal tubular defect that is related to deteriorating liver function and hyperaldosteronism. With progression of liver disease and portal hypertension, renal blood flow declines because of the hepatorenal reflex, and is then maintained by the vasoactive hormonal systems. With increasing peripheral vasodilatation, intrarenal factors for maintenance of renal perfusion cause intense cortical vasoconstriction. The systemic vasoactive factors are predominantly compensatory; any attempts to counteract their action risk circulatory collapse. Future studies should be directed at intrarenal factors. The ideal drug for the treatment of portal hypertension would reduce portal pressure, increase renal blood flow, and produce insignificant changes in arterial pressure.

Entities:  

Mesh:

Year:  1997        PMID: 9357420     DOI: 10.1016/S0140-6736(97)07503-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  16 in total

Review 1.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

2.  Ammonia inhibits long-term potentiation via neurosteroid synthesis in hippocampal pyramidal neurons.

Authors:  Y Izumi; N Svrakic; K O'Dell; C F Zorumski
Journal:  Neuroscience       Date:  2012-12-29       Impact factor: 3.590

3.  End-stage Liver Disease in Children.

Authors:  Robert H. Squires
Journal:  Curr Treat Options Gastroenterol       Date:  2001-10

4.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

Review 5.  Neuropsychological aspects of liver disease and its treatment.

Authors:  R E O'Carroll
Journal:  Neurochem Res       Date:  2007-10-24       Impact factor: 3.996

6.  Saccadic latency in hepatic encephalopathy: a pilot study.

Authors:  Florian Krismer; Jonathan C P Roos; Melanie Schranz; Ivo W Graziadei; Sergei Mechtcheriakov; Wolfgang Vogel; R H S Carpenter; Heinz Zoller
Journal:  Metab Brain Dis       Date:  2010-09-18       Impact factor: 3.584

7.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

8.  Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy.

Authors:  Falk-R Miese; Hans-Jörg Wittsack; Gerald Kircheis; Arne Holstein; Christian Mathys; Ulrich Mödder; Mathias Cohnen
Journal:  World J Gastroenterol       Date:  2009-11-07       Impact factor: 5.742

9.  Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study.

Authors:  Thomas Dethloff; Flemming Tofteng; Hans-Jorgen Frederiksen; Michael Hojskov; Bent-Adel Hansen; Fin-Stolze Larsen
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

10.  Enhanced renal ammonia excretion following volume expansion in patients with well compensated cirrhosis of the liver.

Authors:  R Jalan; D Kapoor
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.